• Return to Headlines

Aerie Pharmaceut Looks to Continue to Trade Below its Annual-Low Share Price Today

By Amy Schwartz

Aerie Pharmaceut (NASDAQ:AERI) traded today at a new 52-week low of $24.58. So far today approximately 74,000 shares have been exchanged, as compared to an average 30-day volume of 736,000 shares.

Over the past year, Aerie Pharmaceuthas traded in a range of $24.58 to $74.75 and are now at $24.58. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.2% while the 200-day MA has slid 1.2%.

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases.

Aerie Pharmaceut has overhead space with shares priced $24.58, or 70.1% below the average consensus analyst price target of $82.30. The stock should find initial resistance at its 50-day moving average (MA) of $34.31 and further resistance at its 200-day MA of $42.57.

SmarTrend recommended that its subscribers protect gains by selling shares of Aerie Pharmaceut on May 31st, 2019 by issuing a Downtrend alert when the shares were trading at $36.58. Since that call, shares of Aerie Pharmaceut have fallen 31.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows aerie pharmaceut

Ticker(s): AERI